Core Viewpoint - Yisheng Pharmaceutical announced the approval of its 2025 semi-annual report and summary by the company's ninth board of directors during its second meeting [2] Group 1 - The announcement was made on the evening of August 22 [2] - The report includes financial performance and operational highlights for the first half of 2025 [2]

Core Viewpoint - Yisheng Pharmaceutical announced the approval of its 2025 semi-annual report and summary by the second meeting of the ninth supervisory board [2] Group 1 - The announcement was made on the evening of August 22 [2] - The report includes financial performance and operational updates for the first half of 2025 [2]

Core Insights - Yisheng Pharmaceutical (002566) reported that as of August 20, 2025, the total number of shareholders is 21,920 [1] Company Summary - The company has engaged with investors through an interactive platform, providing updates on shareholder statistics [1]

Core Viewpoint - Yisheng Pharmaceutical reported a decline in revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for the first half of 2025 was 328 million yuan, a year-on-year decrease of 5.75% [1] - The net profit attributable to shareholders was 18.76 million yuan, down 43.71% compared to the previous year [1] - Basic earnings per share were 0.0567 yuan, reflecting a decline of 43.69% year-on-year [1] Dividend Policy - The company announced plans not to distribute cash dividends, issue bonus shares, or increase capital through reserves [1]

Core Viewpoint - The board of directors of Jilin Province Jianshan Yisheng Pharmaceutical Co., Ltd. convened its second meeting of the ninth session on August 22, 2025, to review and approve the 2025 semi-annual report and its summary [1][2]. Group 1 - The meeting was attended by all 9 directors, and the resolutions were passed with unanimous consent (9 votes in favor, 0 against, 0 abstentions) [1]. - The meeting was legally valid and complied with the provisions of the Company Law and the Articles of Association [1]. - The full text of the 2025 semi-annual report is available on the designated information disclosure website, Juchao Information Network [1].

Core Points - The company held its ninth supervisory board's second meeting on August 22, 2025, where all three attending supervisors approved the 2025 semi-annual report [1][2] - The supervisory board confirmed that the procedures for preparing and reviewing the semi-annual report complied with relevant laws and regulations, ensuring the report accurately reflects the company's actual situation without any false records or misleading statements [1][2] Summary by Sections - **Meeting Details** - The meeting was convened and conducted in accordance with the Company Law and relevant regulations, with all three supervisors present [1] - **Approval of Semi-Annual Report** - The supervisory board unanimously approved the 2025 semi-annual report with a vote of 3 in favor, 0 against, and 0 abstentions [1] - **Report Verification** - The supervisory board verified that the report's preparation and review processes met legal and regulatory standards, confirming its authenticity and completeness [1]

益盛药业8月22日晚间发布公告称，公司第九届第二次董事会会议于2025年8月22日在公司四楼会议室召 开。会议审议了《2025年半年度报告及其摘要》等文件。 （文章来源：每日经济新闻） ...

（文章来源：每日经济新闻） 益盛药业8月22日晚间发布半年度业绩报告称，2025年上半年营业收入约3.28亿元，同比减少5.75%；归 属于上市公司股东的净利润约1876万元，同比减少43.71%；基本每股收益0.0567元，同比减少43.69%。 ...

吉林省集安益盛药业股份有限公司 2025 年半年度财务报告 吉林省集安益盛药业股份有限公司 2025 年半年度财务报告 （未经审计） 2025 年 8 月 1 吉林省集安益盛药业股份有限公司 2025 年半年度财务报告 2025 年半年度财务报告 一、审计报告 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为：元 1、合并资产负债表 编制单位：吉林省集安益盛药业股份有限公司 2025 年 06 月 30 日 单位：元 | 项目 | 期末余额 | 期初余额 | | --- | --- | --- | | 流动资产： | | | | 货币资金 | 101,981,306.14 | 71,479,841.19 | | 结算备付金 | | | | 拆出资金 | | | | 交易性金融资产 | 454,508,208.42 | 459,671,708.03 | | 衍生金融资产 | | | | 应收票据 | 1,089,433.40 | 1,092,066.42 | | 应收账款 | 163,007,087.21 | 149,535,387.68 | | 应收款项融资 ...

| 非经营性资金占 | 资金占用方名称 | 占用方与上市公 | 上市公司核算的 | 2025年初占用 | 2025年1-6月占用累计发 | 2025年1-6月占用 资金的利息（如有 | 2025年1-6月偿 | 2025年6月30日 | 占用形成原因 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 用 | | 司的关联关系 | 会计科目 | 资金余额 | 生金额（不含利息） | | 还累计发生额 | 占用资金余额 | | | | | | | | | | ） | | | | | | 控股股东、实际 | | | | | | | | | | 非经营性占用 | | 控制人及其附属 企业 | | | | | | | | | | 非经营性占用 | | 小 计 | —— | —— | —— | | | | | | —— | —— | | 前控股股东、实 | | | | | | | | | | 非经营性占用 | | 际控制人及其附 属企业 | | | | | | | | | | 非经营性占用 | | 小 计 | —— ...